← Back to Search

Technology Intervention for High Blood Pressure

Q: How many people total are allowed to join this experiment?

<p>The listing on clinicaltrials.gov reveals that this study is currently seeking participants. The trial was first advertised on February 14th, 2021 and has been updated recently on March 15th, 2022. So far, 1 location has recruited 208 patients.</p>

Q: Are new patients being accepted into this trial at this time?

<p>The most up-to-date information on clinicaltrials.gov indicates that this study is currently searching for patients to enroll. The trial was first announced on February 14th, 2021 and has undergone one edit since then - taking place on March 15th, 2022.</p>

N/A

Recruiting

Led By Carolyn Still, PhD

Research Sponsored by Case Western Reserve University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Prescribed at least two hypertensive, one of which is a diuretic/thiazide and or calcium channel blocker antihypertensive medication

50 years of age or older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline - 6 months

Awards & highlights

Study Summary

This trial will test a digital health intervention to improve hypertension control in African American older adults.

Who is the study for?

This trial is for African American individuals over 50 with high blood pressure (BP≥130/80 but <160/90 mmHg), taking at least two BP medications including a diuretic or calcium channel blocker, and who own a smartphone. It's not for those who've had major cardiovascular events in the past year, have cognitive impairments, use other medication apps, show high BP variability, or have severe kidney disease.Check my eligibility

What is being tested?

The OPTIMA-BP trial tests an intervention using mobile health technologies to improve medication adherence and manage high blood pressure among older African Americans. The study aims to see if this tech-based support can help control BP better and reduce health disparities.See study design

What are the potential side effects?

Since the intervention involves technology use rather than medications or invasive procedures, direct side effects are minimal. However, participants may experience challenges related to technology use such as privacy concerns or stress from learning new tools.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am taking two blood pressure medicines, including a water pill or calcium blocker.

Select...

I am 50 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline - 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline - 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline - 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Blood Pressure Control

Health Related Quality of Life (HRQOL)

Secondary outcome measures

Biological risk markers

Controlled BP (<130/80 mmHg)

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention: OPTIMA-BP ImplementationExperimental Treatment1 Intervention

Participants randomized to OPTIMA-BP intervention for 6 months then observed for a 6 month follow up period

Group II: Waitlist: OPTIMA-BP implementationActive Control1 Intervention

Participants randomized to waitlist for 6 months, then offered the OPTIMA-BP intervention for 6 months.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Case Western Reserve UniversityLead Sponsor

299 Previous Clinical Trials

259,742 Total Patients Enrolled

University Hospitals Cleveland Medical CenterOTHER

317 Previous Clinical Trials

340,049 Total Patients Enrolled

Carolyn Still, PhDPrincipal InvestigatorCase Western Reserve University, School of Nursing

1 Previous Clinical Trials

125 Total Patients Enrolled

Media Library

OPTIMA-BP Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05293756 — N/A

High Blood Pressure Research Study Groups: Intervention: OPTIMA-BP Implementation, Waitlist: OPTIMA-BP implementation

High Blood Pressure Clinical Trial 2023: OPTIMA-BP Intervention Highlights & Side Effects. Trial Name: NCT05293756 — N/A

OPTIMA-BP Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05293756 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people total are allowed to join this experiment?

"The listing on clinicaltrials.gov reveals that this study is currently seeking participants. The trial was first advertised on February 14th, 2021 and has been updated recently on March 15th, 2022. So far, 1 location has recruited 208 patients."

Answered by AI

Are new patients being accepted into this trial at this time?

"The most up-to-date information on clinicaltrials.gov indicates that this study is currently searching for patients to enroll. The trial was first announced on February 14th, 2021 and has undergone one edit since then - taking place on March 15th, 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)

Carolyn Still 2021. "OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05293756.